Millbrook Healthcare has been acquired by Cairngorm Capital Partners LLP
The private shareholders of Millbrook Healthcare have sold the company to Cairngorm Capital Partners LLP.
Millbrook is a well-established nationwide provider of equipment, assessment and home-based services to help people live more independently, at home, for longer. The company supports individuals, along the care pathway through the provision of aids, ranging from walkers and frames through to bespoke wheelchairs and specialist active pressure care mattresses. Headquartered in Southampton, Millbrook has 28 depots across the UK, employs 1,000 people and offers a fully integrated service to public authorities.
Cairngorm Capital provides equity capital, strategic advice and management expertise to ambitious companies. In partnership with the long-established management team, it is keen to take advantage of the expected expansion of community care services in the UK and continue to deliver an industry-leading level of service to its key stakeholders.
Oaklins Smith & Williamson, based in the UK, advised the seller in this transaction. The team worked with the directors and shareholders of Millbrook to deliver a successful sale to a partner with the appropriate strategic and operating experience to take the business through its next phase of growth.



Colin Croll
Chairman, Millbrook Healthcare
Talk to the deal team
Related deals
Bolster Investment Partners has acquired a majority stake in Eternal Sun
Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.
Learn moreCerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Learn moreiwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Learn more